GAMCO INVESTORS, INC. ET AL

Position in NEO — Neogenomics Inc

CIK 807249 GREENWICH, CT

Position in NEO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$742,000

+$553,840 QoQ

Shares Held

100,000

+525.0% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GAMCO INVESTORS, INC. ET AL holds $7,314,895 across 6 Diagnostics & Research names. NEO ranks #3 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GRAL	GRAIL, Inc.	66,758	$3,450,053
2	TMO	Thermo Fisher Scientific Inc.	4,533	$2,228,105
3	NEO	Neogenomics Inc This page	100,000	$742,000
4	WAT	Waters Corp /De/	1,314	$391,309
5	DHR	Danaher Corp /De/	1,603	$303,928
6	OPK	Opko Health, Inc.	175,000	$199,500

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$742,000	100,000	+525.0%	Shares	Sole	2026-05-14
2025-12-31	$188,160	16,000	0.0%	Shares	Sole	2026-02-05
2025-09-30	$123,520	16,000	+45.5%	Shares	Sole	2025-11-12
2025-06-30	$80,410	11,000	-63.9%	Shares	Sole	2025-08-13
2022-06-30	$248,656	30,510	-2.2%	Shares	Sole	2022-08-12
2022-03-31	$379,201	31,210	+5.8%	Shares	Sole	2022-05-18
2021-12-31	$1,006,881	29,510	-2.6%	Shares	Sole	2022-02-11
2021-09-30	$1,462,154	30,310	-0.3%	Shares	Sole	2021-11-12
2021-06-30	$1,373,619	30,410	+7.8%	Shares	Sole	2021-08-13
2021-03-31	$1,360,568	28,210	-31.6%	Shares	Sole	2021-05-14
2020-12-31	$2,220,900	41,250	-12.9%	Shares	Sole	2021-02-05
2020-09-30	$1,746,741	47,350	-18.9%	Shares	Sole	2020-11-06
2020-06-30	$1,807,683	58,350	-21.4%	Shares	Sole	2020-08-13
2020-03-31	$2,048,385	74,190	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.